Literature DB >> 15040041

Clinical features and risk factors of patients with fatty liver in Guangzhou area.

Qi-Kui Chen1, Hai-Ying Chen, Kai-Hong Huang, Ying-Qiang Zhong, Ji-Ao Han, Zhao-Hua Zhu, Xiao-Dong Zhou.   

Abstract

AIM: There is still no accepted conclusion regarding the clinical features and related risk factors of patients with fatty liver. The large-scale clinical studies have not carried out yet in Guangzhou area. The aim of the present study was to investigate the clinical features and related risk factors of patients with fatty liver in Guangzhou area.
METHODS: A total of 413 cases with fatty liver were enrolled in the study from January 1998 to May 2002. Retrospective case-control study was used to evaluate the clinical features and related risk factors of fatty liver with logistic regression.
RESULTS: Obesity (OR: 21.204), alcohol abuse (OR: 18.601), type 2 diabetes mellitus (OR: 4.461), serum triglyceride (TG) (OR: 3.916), serum low-density lipoprotein cholesterol (LDL-C) (OR: 1.840) and fasting plasma glucose (FPG) (OR: 1.535) were positively correlated to the formation of the fatty liver. The levels of serum alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) increased mildly in the patients with fatty liver and were often less than 2-fold of the normal limit. The higher abnormalities of aspartate aminotransferase (AST) levels (42.9%) with AST/ALT more than 2(17.9%) were found in patients with alcoholic fatty liver (AFL) than those with nonalcoholic fatty liver (NAFL) (16.9% and 5.0% respectively). The elevation of serum TG, cholesterol (CHOL), LDL-C was more common in patients with NAFL than with AFL.
CONCLUSION: Obesity, alcohol abuse, type 2 diabetes mellitus and hyperlipidemia may be independent risk factors of fatty liver. The mildly abnormal hepatic functions can be found in patients with fatty liver. More obvious damages of liver function with AST/ALT usually more than 2 were noted in patients with AFL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15040041      PMCID: PMC4727014          DOI: 10.3748/wjg.v10.i6.899

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  [A study on the epidemiological characteristics of obesity in Chinese Adults].

Authors:  W Wang; K Wang; T Li
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2001-04

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

3.  Non-alcoholic steatohepatitis: another disease of affluence.

Authors:  O James; C Day
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

4.  Effect of lipid on proliferation and activation of rat hepatic stellate cells (I).

Authors:  Lun-Gen Lu; Min-De Zeng; Ji-Qiang Li; Jing Hua; Jian-Gao Fan; Zhu-Ping Fan; De-Kai Qiu
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

Review 5.  Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.

Authors:  F H Luyckx; P J Lefebvre; A J Scheen
Journal:  Diabetes Metab       Date:  2000-04       Impact factor: 6.041

6.  [Prevalence and factors associated to the presence of fatty liver in apparently healthy adult men].

Authors:  A Parés; R Tresserras; I Núñez; M Cerralbo; P Plana; F J Pujol; J Massip; L Caballería; C Bru; J Caballería; J Vidal; L Salleras; J Rodés
Journal:  Med Clin (Barc)       Date:  2000-04-22       Impact factor: 1.725

Review 7.  Nonalcoholic steatohepatitis.

Authors:  S G Sheth; F D Gordon; S Chopra
Journal:  Ann Intern Med       Date:  1997-01-15       Impact factor: 25.391

8.  Body mass index as a predictor of hepatic steatosis in living liver donors.

Authors:  M E Rinella; E Alonso; S Rao; P Whitington; J Fryer; M Abecassis; R Superina; S L Flamm; A T Blei
Journal:  Liver Transpl       Date:  2001-05       Impact factor: 5.799

Review 9.  Nonalcoholic steatohepatitis.

Authors:  B A Neuschwander-Tetri; B R Bacon
Journal:  Med Clin North Am       Date:  1996-09       Impact factor: 5.456

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  7 in total

1.  Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease.

Authors:  Cheng-Fu Xu; Chao-Hui Yu; You-Ming Li; Lei Xu; Juan Du; Zhe Shen
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

2.  Effect of Sinai san decoction on the development of non-alcoholic steatohepatitis in rats.

Authors:  Qi Zhang; Yan Zhao; Deng-Ben Zhang; Li-Jun Sun
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

3.  Non-alcohol fatty liver disease in Asia: Prevention and planning.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Mohamad Reza Zali
Journal:  World J Hepatol       Date:  2015-07-08

4.  Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals.

Authors:  Fang Song; Mei-Lin Xie; Lu-Jia Zhu; Ke-Ping Zhang; Jie Xue; Zhen-Lun Gu
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

5.  Alcohol drinking may not be a major risk factor for fatty liver in Japanese undergoing a health checkup.

Authors:  Tamaki Yamada; Mitsuru Fukatsu; Sadao Suzuki; Takashi Yoshida; Shinkan Tokudome; Takashi Joh
Journal:  Dig Dis Sci       Date:  2009-01-21       Impact factor: 3.199

6.  Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults.

Authors:  Mark M Haenle; Stefan O Brockmann; Martina Kron; Ursula Bertling; Richard A Mason; Gerald Steinbach; Bernhard O Boehm; Wolfgang Koenig; Peter Kern; Isolde Piechotowski; Wolfgang Kratzer
Journal:  BMC Public Health       Date:  2006-09-18       Impact factor: 3.295

7.  Association of alcohol consumption with prevalence of fatty liver after adjustment for dietary patterns: Cross-sectional analysis of Japanese middle-aged adults.

Authors:  Ryoko Tajima; Fumiaki Imamura; Takeshi Kimura; Satomi Kobayashi; Katsunori Masuda; Kaoruko Iida
Journal:  Clin Nutr       Date:  2019-07-26       Impact factor: 7.324

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.